About Us
About Us
Group Introduction Management Team Development Strategy Corporate Culture Milestones Contact Us
News
News
News
Global
Global
Global Layout Asia North America Africa Europe
Products
Products
API Preparation
R&D and Innovation
R&D and Innovation
Overview R&D Centers Development Progress Technology Platform Introduction To Key Projects
Partnership
Partnership
We Seek We Offer
Investor Relations
Investor Relations
Corporate Governance Financial Highlight Periodical Ad-hoc Investor Interaction

En

English 中文
  • About Us
    Group Introduction Management Team Development Strategy Corporate Culture Milestones Contact Us
  • News
    News
  • Global
    Global Layout Asia North America Africa Europe
  • Products
    API Preparation
  • R&D and Innovation
    Overview R&D Centers Development Progress Technology Platform Introduction To Key Projects
  • Partnership
    We Seek We Offer
  • Investor Relations
    Corporate Governance Financial Highlight Periodical Ad-hoc Investor Interaction
Periodical
CURRENT LOCATION: HOME > Investor Relations > Periodical

Corporate Governance

Financial Highlight

Periodical

Ad-hoc

Investor Interaction

Periodical

人福医药2025年第一季度报告

2025.04.29

人福医药2024年年度报告

2025.04.29

人福医药2024年第三季度报告

2024.10.28

人福医药2024年半年度报告

2024.07.26

人福医药2024年第一季度报告

2024.04.29

人福医药2023年年度报告

2024.03.29

人福医药2023年第三季度报告

2023.10.29

人福医药2023年半年度报告

2023.09.05

人福医药2023年第一季度报告

2023.05.10

人福医药2022年年度报告(修订版)

2023.03.30

人福医药2022年第三季度报告(修订版)

2022.11.10

人福医药2022年半年度报告(修订版)

2022.08.30
  •  
  • 1
  • 2
  • 3
  • 4
  • 5
  •  
  • CURRENT LOCATION:

    HOME > Investor Relations> Periodical
    About Us
    Group Introduction
    Management Team
    Development Strategy
    Corporate Culture
    Milestones
    Contact Us
    News
    News
    Global
    Global Layout
    Asia
    North America
    Africa
    Europe
    Products
    API
    Preparation
    R&D and Innovation
    Overview
    R&D Centers
    Development Progress
    Technology Platform
    Introduction To Key Projects
    Partnership
    We Seek
    We Offer
    Investor Relations
    Corporate Governance
    Financial Highlight
    Periodical
    Ad-hoc
    Investor Interaction

    COPYRIGHT 2024 HUMANWELL GROUP ALL RIGHTS RESERVED.

    Privacy protection Legal statement
    Technical Support: Lucky xp
    Group Subsidiary GROUP SUBSIDIARY
    Yichang Humanwell Pharmaceutical Co., Ltd Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Wuhan Humanwell Pharmaceutical Co., Ltd Xinjiang Uyghur Pharmaceutical Co., Ltd. Humanwell Puke Pharmaceutical (Wuhan) Co., Ltd Yichang Sanxia Pharmaceutical Co., Ltd Epic Pharma, LLC Beijing Baron Medical Equipment Co., Ltd. Wuhan Tianrun Health Products Co., Ltd.
    QRCode
    Group Subsidiary GROUP SUBSIDIARY
    Yichang Humanwell Pharmaceutical Co., Ltd Hubei Gedian Humanwell Pharmaceutical Co.,Ltd. Wuhan Humanwell Pharmaceutical Co., Ltd Xinjiang Uyghur Pharmaceutical Co., Ltd. Humanwell Puke Pharmaceutical (Wuhan) Co., Ltd Yichang Sanxia Pharmaceutical Co., Ltd Epic Pharma, LLC Beijing Baron Medical Equipment Co., Ltd. Wuhan Tianrun Health Products Co., Ltd.
    QRCode

    COPYRIGHT 2024 HUMANWELL GROUP ALL RIGHTS RESERVED.

    Privacy protection Legal statement
    Technical Support: Lucky xp